These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38775910)

  • 1. Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants.
    Park JW; Chung H; Kim JM; Kim NY; Hong SH; Kim KA; Park JY
    Drugs R D; 2024 Jun; 24(2):179-186. PubMed ID: 38775910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
    Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
    Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects.
    Min KL; Park MS; Jung J; Chang MJ; Kim CO
    Clin Ther; 2017 Sep; 39(9):1799-1810. PubMed ID: 28803122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects.
    Ryu H; Kim HC; Jeon I; Jang IJ; Cho JY; Kim KT; Oh J
    Drug Des Devel Ther; 2024; 18():2641-2652. PubMed ID: 38974125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects.
    Nwe HH; Bullman JN; Joshi SM; Stylianou A; Kapsi SG
    Clin Pharmacol Drug Dev; 2016 Mar; 5(2):131-40. PubMed ID: 27138026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
.
    Park JS; Jeon JY; Kim MG
    Int J Clin Pharmacol Ther; 2019 Dec; 57(12):612-622. PubMed ID: 31549624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioequivalence of a rosuvastatin/ezetimibe fixed-dose combination tablet versus single agents in healthy male subjects
.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Na S; Kim HJ; Yoon YR; Lee HW
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):43-52. PubMed ID: 29162214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects.
    Oh M; Shin JG; Ahn S; Kim BH; Kim JY; Shin HJ; Shin HJ; Ghim JL
    Drug Des Devel Ther; 2019; 13():991-997. PubMed ID: 31114155
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
    Oh M; Ghim JL; Park SE; Kim EY; Shin JG
    Drug Des Devel Ther; 2018; 12():1157-1164. PubMed ID: 29780236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
    Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects
.
    Park DB; Jang K; Lee JW; Park CW; Lee BH; Kim MG; Jeon JY
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):286-294. PubMed ID: 28079517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
    Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
    Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study.
    Son M; Guk J; Kim Y; Woo Chae D; Heo YA; Soh D; Park K
    Clin Ther; 2016 Aug; 38(8):1845-57. PubMed ID: 27422590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects.
    Nishida C; Matsumoto Y; Fujimoto K; Shirakawa M; Wrishko RE; Behm MO; Furihata K
    Clin Transl Sci; 2019 Nov; 12(6):704-712. PubMed ID: 31365188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Bioequivalence of Fixed-Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open-Label Study in Healthy Volunteers.
    Leong CW; Yee KM; Rani TA; Lau KJ; Ahmad S; Amran A; Mohd Hassan FW; Kumar N
    Clin Pharmacol Drug Dev; 2024 Aug; 13(8):938-946. PubMed ID: 38745538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects.
    Kim CH; An H; Kim SH; Shin D
    Drug Des Devel Ther; 2017; 11():3461-3469. PubMed ID: 29255347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
    Choi HY; Kim YH; Kim MJ; Noh YH; Lee SH; Bae KS; Lim HS
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers.
    Jia JY; Zhang MQ; Liu YM; Liu Y; Liu GY; Li SJ; Lu C; Weng LP; Qi YL; Yu C
    Clin Ther; 2010 Jul; 32(7):1387-95. PubMed ID: 20678685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants.
    Kim JH; Song JH; Kim M; Hong JH; Sunwoo J; Jung JG
    Adv Ther; 2024 Jul; 41(7):2808-2825. PubMed ID: 38771476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and haemodynamic interactions between amlodipine and losartan in human beings.
    Park JW; Kim KA; Il Kim Y; Park JY
    Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):345-352. PubMed ID: 31058419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.